Last update: Sept. 30, 2014
Minimal risk for breastfeeding and infant.
Excreted into breast milk in a non-significant amount.
Because of pharmacokinetic data (high protein-binding capacity and low oral bioavailability) the observed low excretion into breast milk would be explained.
Nimodipine does not alter secretion of Prolactin.
We do not have alternatives for نيموديبين since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.